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The mechanisms of angiogenesis have been studied
extensively over the past years. The focus, however,
has been almost exclusively on blood vessels, whereas
little effort has been directed toward understanding
lymphangiogenesis and the role of lymphatic vessels
in physiology and pathology. The lymphatic system,
acting in concert with the blood vascular system, is
of fundamental importance in maintaining tissue
homeostasis, and disorders of the lymphatic system
are common, often resulting in chronic, disabling
conditions. This overview summarizes the most
important aspects of the structure and function of
the lymphatic system with emphasis on the skin lym-
phatic vasculature and the differences between blood
and lymphatic vessels. Special attention has been
given to the methods employed in research of the
lymphatic system. Finally, we describe molecular
mechanisms involved in the regulation of lymphan-
giogenesis. Vascular endothelial growth factor and
vascular endothelial growth factor-C, expressed by
distinct skin cell populations, play an important role
in the molecular control of skin angiogenesis and
lymphangiogenesis. Key words: lymphatic vessels/lymph-
angiogenesis/skin/VEGF-C. Journal of Investigative
Dermatology Symposium Proceedings 5:14±19, 2000
O
ur understanding of the biology of the lymphatic
system is well illustrated by the word lymphatic
itself; the derivation of the latin word lymphaticus
signi®es ``distracted and confused'' (Witte et al,
1997). Whereas angiogenesis involving blood
vessels has been studied extensively over the past decades, the
lymphatic system has received only scant attention and molecular
mechanisms regulating lymphatic functions and growth have
remained largely unknown. Although structurally two distinct
systems, the blood and lymphatic vascular system are functionally
interconnected and act together to ensure ¯uid and protein balance
in tissues, cell nutrition, proper immunologic functioning, etc. In
many ways the lymphatic system complements the blood vascular
system. Thus, it is most likely that their growth and functions are
regulated in concert. The regulatory mechanisms and structural
elements shared by and distinct to the lymphatic versus blood
vascular system are only beginning to be disclosed.
DISCOVERY OF THE LYMPHATIC SYSTEM
Lymphatic vessels remained unrecognized for many centuries after
the ®rst description of blood vessels. Whereas the blood vascular
system and most other systems of the body have been known since
ancient times, although knowledge about their organization and
function was inaccurate, the lymphatic system was truly ``dis-
covered'' (Bartels, 1909). The ancient Greeks observed structures
containing colorless ¯uid (Hippocrates spoke of ``white blood'') but
their function was not understood and the signi®cance of the
®nding was not recognized. For almost 2000 years this observation
fell into complete oblivion (Rusznyak et al, 1967). The actual
discovery of lymphatic vessels dates back to the year 1622 when
Gasparo Aselli, a professor of anatomy and surgery in Pavia, Italy,
observed vessels in the mesentery of a well-fed dog that were ®lled
with a white ¯uid (Bartels, 1909; Rusznyak et al, 1967; Haagensen
et al, 1972). He instantly realized that he had made an important
observation and wrote an enthusiastic description of it. Because of
the milky appearance of the vessels, Aselli named them lacteis venis ±
milky veins. This ®rst description of lymphatic vessels was
published by his friends 5 years later, after his death.
Aselli mistakenly believed that the lymph ¯owed to the liver,
where it was transformed to blood. In 1651, Jean Pecquet
discovered the thoracic duct and its entry into the veins, thus
becoming the ®rst person to describe the correct route of the
lymphatic ¯uid into the blood. While it had been assumed at the
time that lymphatic vessels were the main pathway for food
absorption from the intestines, Olaus Rudbeck in Uppsala revealed
that the role of lymphatic vessels is not restricted to food
absorption. He observed that lymphatic vessels are distributed
throughout the body and recognized that these vessels form a
special system, the lymphatic vascular system (Bartels, 1909;
Rusznyak et al, 1967). Thomas Bartholin in Copenhagen, who
independently made similar observations, ®rst introduced the term
lymphaticus in 1653 (Yoffey and Courtice, 1970). Although
Rudbeck and Bartholin suggested that lymphatic vessels may be
involved in the convection of ¯uid ®ltered from blood, the
functions of the lymphatic system remained poorly understood
until 1746 when William Hunter and his pupils at the School of
Anatomy in London demonstrated that lymphatic vessels are the
absorbing vessels throughout the body. Their comprehensive work
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laid the foundations for the modern knowledge of the anatomy,
physiology and pathology of the lymphatic system.
By the end of the eighteenth century, the anatomy of the larger
lymphatic truncs in the body had been correctly elucidated;
however, the structure and the organization of lymphatic capillaries
remained unknown. Studies of the ®ne structure of the lymphatic
system were greatly facilitated by von Recklinghausen's discovery
in 1862 that the borders of endothelial cells stained black with silver
nitrate. It had been thought at the time that the lymph passed from
the blood stream into the lymphatic vessels through a ®ne tubular
system. Recklinghausen denied a direct connection between the
two systems and suggested that the end of the lymphatic capillary
was open and that ¯uid from the interstitial space passed through
these open endings into the lymphatics. He very accurately
described the network of lymphatic capillaries and showed that
they are lined by a single layer of endothelial cells (Rusznyak et al,
1967).
Late in the 19th century Ludwig suggested that the lymph was a
®ltrate derived from blood. His concept was con®rmed in 1896 by
Starling, who demonstrated through a number of sophisticated
experiments that the lymph is formed from the blood by ®ltration
(Yoffey and Courtice, 1970). While Starling had realized that
capillaries leak protein, it was Drinker, early in the 20th century,
who developed the concept of the lymphatic system as one of
absorbing vessels, the main function of which was to return to the
blood stream ¯uid and protein molecules that escape from the
blood circulation (Drinker and Yoffey, 1941).
FUNCTION AND TISSUE DISTRIBUTION OF
LYMPHATIC VESSELS
The lymphatic system is of fundamental importance for the normal
maintenance of ¯uid balance in tissues. In the course of a day, 50%
of the total circulating protein escapes from the blood vessels and
cannot be reabsorbed by the same. Therefore, return of the
extravasated ¯uid and macromolecules into the blood stream is
crucial for the maintenance of plasma volume and to prevent an
increase in tissue pressure. Furthermore, consistent clearance of
excess ¯uid from the interstitium assures adequate cell nutrition by
keeping the distances between cells and capillaries to a minimum.
The lymphatic system is also involved in the response of the
organism to infection. Lymphatic vessels direct antigen presenting
cells to the lymph nodes and are thus essential for the development
of cellular immunity. In the skin, lymphatic vessels are an important
exit path for Langerhans cells. Impairment of lymphatic function-
ing, e.g., inadequate transport of ¯uid, macromolecules, or cells
from the interstitium, leads to a number of diseases that are
characterized by edema, impaired immunity, and ®brosis (Ryan,
1989; Witte et al, 1997).
Although lymphatic vessels generally accompany blood vessels in
tissues, the density of lymphatic plexus does not always parallel the
abundance of blood supply. There are no lymphatic vessels in the
central nervous system, and lymphatic vessels do not penetrate as far
as blood vessels in several other well vascularized tissues. In lobular
organs such as liver and mammary gland, lymphatic capillaries do
not penetrate the lobules but are arranged around the periphery. In
the spleen and the thymus, lymphatics have been observed only in
the capsule and the thickest trabeculae, and in voluntary muscle
they are con®ned to the fascial planes and do not enter the muscle
bundles. Other tissues, such as the epidermis, the cornea, the
crystalline lens of the eye, and cartilage are devoid of both blood
and lymphatic vessels. Tissues near the surface of the body, e.g., the
mucous membranes of the gastro-intestinal and respiratory tracts
and the skin, are usually richly supplied with lymphatic vessels
(Yoffey and Courtice, 1970).
Lymphatic vessels themselves are supplied by a rich network of
nutritive blood vessels. In fact, a blood capillary network is present on
the surface of all lymphatic vessels except the lymph capillaries.
Abundant blood supply probably re¯ects the relatively high oxygen
requirements of cells due to lymph vessel contractility (Evans, 1907).
THE SKIN LYMPHATIC SYSTEM
The cutaneous blood microvasculature is organized into upper and
lower horizontal plexuses with the dermal capillary loops arising
from the upper plexus (Braverman, 1989). Likewise, the lymphatic
vessels of human skin form two plexuses (Fig 1) (Kampmeier,
1928; Zhdanov, 1952; Ryan, 1978). The super®cial plexus extends
into the dermal papillae and is found near the subpapillary arterial
network. It consists of thin vessels without valves (Sabin, 1904).
Whereas the bulk of the blood microcirculation resides immedi-
ately below the epidermis, lymphatic vessels are situated somewhat
more distant. From the super®cial plexus, branches drain vertically
into a series of larger lymphatic vessels in the lower dermis and the
super®cial zone of the subcutaneous tissue (Forbes, 1937). The
deep lymphatic plexus is situated below the second arterial
network. Similar to the collecting venules of the lower dermis,
the deep lymphatic vessels contain numerous valves. Whereas
blood vessels are found at the junction of the fat layer and the
dermis and within the fat lobules, lymphatic vessels are not
contained within the subcutaneous adipose tissue (Zhdanov, 1952;
Braverman and Keh-Yen, 1981). Although blood and lymphatic
capillaries may lie immediately adjacent to each other they never
anastomose (Clark and Clark, 1937).
The described cutaneous lymph vessel con®guration is similar
throughout the body; however, certain areas such as the ®ngers, the
palm of the hand, the sole of the foot, and the scrotum appear to
have a more abundant lymphatic network. The structure of the
cutaneous lymphatics is dependent on the structure of the skin at
the particular site and can thus vary in different areas. Generally,
lymphatic vessels have a regular, uniform shape in the areas where
the skin is ®rm and thick, whereas the shapes are more variable in
regions where the skin is thin and loose.
Blood and lymphatic vessels are similar in that they form a system
of tubes with a continuous endothelial lining; however, re¯ecting
differences in their function, the structure of lymphatic capillaries is
different from that of blood capillaries in several important aspects
(Fig 2) (Casley-Smith and Florey, 1961; Leak, 1970; Daroczy,
1988). (1) The lymphatics generally possess a wider and more
irregular lumen than blood capillaries. In the papillary dermis, the
outside diameters of blood vessels are generally in the 17±22 mm
range (Braverman, 1989), whereas lymphatic vessels can reach up to
60 mm in diameter. (2) Lymphatic capillaries are characterized by an
endothelium with extremely attenuated cytoplasm, except in the
Figure 1. Relation between the lymphatic and blood-capillary
network of the skin. Lymphatic vessels (white); arterial (red) and venous
(blue) parts of the blood-capillary network (modi®ed after Zhdanov, 1952).
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perinuclear region. Whereas postcapillary venules in the horizontal
dermal plexus that are comparable in size with the lymphatic vessels
of the area possess a vessel wall thickness of 3.5±5 mm, the vessel
walls of lymphatic capillaries measure 50±100 nm, except in the
nuclear region where the vessel wall thickness can reach up to
6 mm. (3) Lymphatic endothelial cells contain numerous ®ne
cytoplasmic ®laments whose longitudinal orientation implicates
their contractile function. (4) In contrast to blood vessels, lymphatic
capillaries have either no or only a poorly developed basal lamina
and (5) they are not encircled by pericytes. (6) Tight junctions and
adherens junctions, which are major types of intercellular junctions
in blood vessels, are not as frequently seen in lymphatics.
Nevertheless, they are implicated in maintaining ®rm cell±cell
adhesion along the lymphatic vessel. In lymphatic vessels these
adhesive molecules represent focal points of adhesion instead of
connecting adjacent endothelial cells over entire cell boundaries as
in blood vessels. The fact that skin blood and lymphatic capillaries
do not anastomose suggests the possible existence of lymphatic
endothelium speci®c cell adhesion molecules. (7) One of the most
striking characteristics of lymphatic capillaries is that they come into
an intimate association with the adjacent interstitial areas. The end
of the lymphatic capillary is open for free passage of ¯uid and
particles into the vessel, and lymphatic endothelial cells are closely
connected to the surrounding tissue by ®ne strands of reticular
®bers and collagen (Pullinger and Florey, 1935). These anchoring
®laments are attached to the abluminal surface of the cells and
extend deeply into the connective tissue, thereby ®rmly attaching
lymphatic endothelium to interstitial collagen ®bers and to the
network of elastic ®bers (Fig 2). Elastic ®bers represent a low
resistance path for the transinterstitial transport of ¯uid and are thus
regarded as prelymphatic pathways (Ryan, 1989). In the skin, they
are ideally arranged for directing ¯uid into the lymphatics; in the
upper dermis ®bers are oriented perpendicularly whereas they are
oriented horizontally in the lower dermis.
Lymphatic capillaries respond to increased demands for ¯uid
transport by widening their lumina. An increase in the interstitial
¯uid volume stretches the connective tissue ®bers and pulls the
lymphatic vessels open, despite an increase in the interstitial
pressure. Greater demand for ¯uid uptake is also accommodated by
opening of intercellular junctions. (8) Overlapping intercellular
junctions formed by extensive superimposing of adjacent endothe-
lial cells are a property unique to lymphatic vessels. By being
loosely apposed to each other over long distances, lymphatic
endothelial cells cast intercellular clefts. When interstitial ¯uid
pressure rises and exceeds the pressure within the lymphatic vessel,
anchoring ®laments open the intercellular channels by pulling
adjacent endothelial cells apart, thus permitting easy passage of
¯uids and particles into the vessel.
Under normal circumstances, lymphatic capillaries are generally
collapsed. An elevation of interstitial pressure from values of ±7 to
+2 mmHg distends lymphatic vessels and increases lymph ¯ow.
When the interstitial ¯uid pressure is raised to more positive values,
however, there is no further increase in ¯ow. Thus, the inability of
the lymphatic system to accommodate excess ¯uids leads to
edematous conditions as the interstitial ¯uid pressure approaches
+2 mmHg (Guyton, 1965; Taylor et al, 1973). The concept of
anchoring ®laments explains why venules are compressed in
in¯ammatory reactions and other conditions associated with
increased ¯uid accumulation, whereas lymphatics are greatly dilated
(Pullinger and Florey, 1935). The functional state of lymphatic
vessels, however, cannot be determined by their morphology, as
lymphatics can be dysfunctional when overdistended, but also
when they are collapsed. Extensive degradation of the extracellular
matrix, e.g., by hyaluronidase, induces a collapse of lymphatic
vessels and renders them nonresponsive to the changes in the
interstitium. Hence, the functioning of lymphatic vessels is critically
dependent on the extracellular matrix composition, geometry, and
integrity.
LYMPHATIC IMAGING
One major reason for our incomplete understanding of lymphatic
physiology has been the lack of convenient methods to visualize
lymphatic vessels. Classical methods to visualize lymphatics are
interstitial injections of an agent that readily enters the lymphatic
capillaries, spreads throughout the plexus and drains into the
collecting ducts and regional lymph nodes. Anatomists in the last
centuries performed postmortem lymphography by using injection
materials such as water, gelatine, wax, oil, ink, prussian blue, and
mercury. More recently, vital dyes such as Trypan blue, Evans blue,
or patent blue have been used extensively. In most of the earlier
experiments, contrast medium was injected into the tissue from
which it then entered the lymphatic vessels. Later, injection of a
dye was performed ®rst to delineate the peripheral lymphatic vessels
that were then cannulated and infused with a contrast agent directly
into the lumen (Yoffey and Courtice, 1970). Conventional
lymphography is based on the use of a direct oil contrast and has
been extensively used to visualize lymphatic vessels in living
subjects; however, this technique has notable limitations because it
is frequently accompanied by serious side-effects. More recently,
signi®cant advances in lymphatic imaging have been achieved by
introduction of water-soluble contrast agents, isotopes, and
¯uorescent tracers. Fluorescence micrography, providing superior
contrast and resolution, is particularly suitable for visualization of
microlymphatics. FITC-labeled tracers that do not readily enter
Figure 2. Structural features of a dermal lymphatic capillary.
Lymphatic endothelial cells are ®rmly attached to the collagen and elastin
®bers in tissues by anchoring ®laments. An increase of the interstitial
pressure caused by an increased ¯uid volume in tissue stretches the ®bers
and expands the lymphatic lumen. Furthermore, overlapping intercellular
junctions facilitate opening of the intercellular channels, allowing easy
passage of ¯uid and macromolecules into the vessel (modi®ed after Leak,
1970).
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blood vessels, e.g., high molecular mass dextranes, have been
successfully used to visualize lymphatic capillaries in experimental
models (Fig 3). Lymphangioscintigraphy (isotope lymphography)
that also allows functional and quantitative insights into the lymph
¯ow kinetics, currently represents the preferred method for
imaging lymphatics in patients. Other promising techniques include
computed tomography and magnetic resonance imaging, the latter
being particularly promising for visualization of dermal lymphatics
(Witte et al, 1993).
Research of the lymphatic system has been hampered by the lack
of positive markers that reliably distinguish blood from lymphatic
endothelial cells. Lymphatic vessels, in particular capillaries, have
been mostly identi®ed by certain features that they either lack or
express at lower levels when compared with blood vessels
(Table I). The most ubiquitous endothelial cell marker, CD31
(PECAM-1), is expressed in both blood and lymphatic vessels
(Albelda et al, 1991; Erhard et al, 1996). Based on their poorly
developed basement membrane (Leak and Burke, 1966; Leak,
1970), lymphatic vessels can be identi®ed by double immunostain-
ings with antibodies directed to the CD31 antigen and to
components of the basement membrane such as collagen type IV
or laminin (Nerlich and Schleicher, 1991). Likewise, lymphatic
vessels can be identi®ed as CD31+/PAL-E-vessels because the
PAL-E antigen is a speci®c marker for blood vasculature
(Schlingemann et al, 1985, 1991). Lymphatic vessels appear not
to express ICAM-1, VCAM-1, and E-selectin, adhesion molecules
commonly expressed in blood vascular endothelium (Erhard et al,
1996). Desmoplakin and plakoglobin, cell adhesion molecules
contained within complexus adhaerentes junctions, are found in
lymphatic but not in blood vessels, yet they are also expressed in
desmosomes of strati®ed squamous epithelium (Schmelz et al,
1994). High activities of the enzymes 5¢-nucleotidase, adenylate,
and guanylate cyclase have been reported speci®cally in lymphatic
endothelial cells (Nishida and Ohkuma, 1992, 1993; Weber et al,
1994). Moreover, the surface charge distribution appears to be
reversed in lymphatic vessels as compared with blood vessels, with a
high density of anionic sites along the luminal side (Leak, 1986).
Very recently, several novel molecules have been identi®ed that
allow a more precise distinction between lymphatic and blood
vascular endothelium. An antibody to the receptor for the vascular
endothelial growth factor-C (VEGF-C), VEGFR-3 (¯t4), has been
shown to selectively label lymphatic endothelia in several normal
tissues and in vascular tumors of lymphatic origin (Jussila et al,
1998). Likewise, podoplanin has been found to be selectively
expressed in the normal lymphatic endothelium of the skin and
kidney, and in vascular tumors of lymphatic origin (Breiteneder-
Geleff et al, 1999; Weninger et al, 1999). Most recently, a novel
hyaluronan receptor termed LYVE-1 has been shown to be
restricted to lymphatic vessels in a number of normal tissues
(Banerji et al, 1999). In human skin, strong expression of LYVE-1 is
detected speci®cally in the CD31+/PAL-E-vessels, revealing a
remarkably rich lymphatic network (Fig 4).
MOLECULAR REGULATION OF
LYMPHANGIOGENESIS IN THE SKIN
Lymphatic capillaries possess a great capacity to regenerate
(Daroczy, 1988; Witte et al, 1997). Growth of lymphatic vessels
has been observed in various normal and pathologic processes such
as wound healing, in¯ammation, and tumor growth. During
wound healing, lymphangiogenesis is as prominent as angiogenesis
of blood vessels. Generally, regeneration of lymphatics succeeds
that of blood vessels, sometimes with a considerable delay. Studies
using the rabbit ear chamber technique showed that blood vessels
invaded the wound area in an average time of 7 days, whereas the
ingrowth of lymphatic vessels was only observed after 19 days. The
cause of this disparity in the growth rate is unclear (Yoffey and
Courtice, 1970; Witte et al, 1997). The fact that the regeneration of
lymphatic and blood vessels is spatially and temporally coordinated
implies the existence of mutual regulatory mechanisms; however,
the delayed outgrowth of lymphatics suggests different responsive-
ness to the stimuli involved.
Figure 3. Visualization of skin lymphatic vessels by uptake of
FITC-dextrane. High-molecular weight FITC-dextrane (MW 500 000)
was injected intradermally into mouse skin (10 mL of a 2% solution in 0.9 M
NaCl). Skin, turned upside down, was examined 30 min after injection by
using a Leica DM IRBE microscope. Lymphatic vessels (arrow) have taken
up FITC-dextrane from the interstitium and exhibit bright ¯uorescence.
Blood vessels (arrowhead) are unable to absorb the high-molecular mass
dextrane and remain unlabeled. Note that the lymphatic vessel runs in
parallel with a blood vessel.
Table I. Expression of vascular markers in blood and lymphatic vessels
Microvasculature References
Lymphatic Blood
CD31 (PECAM-1) + + Albelda et al, 1991; Erhard et al, 1996
PAL-E ± + Schlingemann et al, 1985; Erhard et al, 1996
basal lamina +/± + Leak, 1970; Nerlich and Schleicher, 1991
desmoplakin + ± Schmelz et al, 1994
5¢-nucleotidase + ± Weber et al, 1994
adenylate/guanylate cyclase + ± Nishida and Ohkuma, 1992; Nishida and Ohkuma, 1993
ICAM-1 ± + Erhard et al, 1996
VCAM ± + Erhard et al, 1996
E-selectin ± + Erhard et al, 1996
VEGFR-3 (¯t-4) + ± Jussila et al, 1998
podoplanin + ± Breiteneder-Geleff et al, 1999; Weninger et al, 1999
LYVE-1 + ± Banerji et al, 1999
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A large number of molecules have been identi®ed that are
implicated in regulating blood vascular angiogenesis, whereas
molecules regulating growth and function of lymphatic vessels
have remained largely unrevealed. Recently, novel members of the
VEGF family of angiogenic growth factors have been identi®ed
that are distinguished by their capacity to stimulate lymphangio-
genesis (Achen et al, 1998; Joukov et al, 1996; Lee et al, 1996).
Similar to the major angiogenic factor VEGF, VEGF-C and
VEGF-D activate the VEGFR-2 (KDR) receptor; however, they
do not bind to the VEGFR-1 (¯t-1). VEGF-C and VEGF-D also
activate the receptor tyrosine kinase VEGFR-3, which has been
regarded as a speci®c marker of lymphatic endothelium (Joukov
et al, 1996; Lee et al, 1996; Achen et al, 1998). Indeed,
overexpression of VEGF-C in the skin of transgenic mice resulted
in hyperplasia of the lymphatic network without obvious effects on
blood vessels (Jeltsch et al, 1997).
In vitro analysis of VEGF-C mRNA expression in different cells
derived from human skin reveals abundant expression of VEGF-C
in dermal ®broblasts and low basal expression levels in keratino-
cytes, melanocytes, and microvascular endothelial cells (Fig 5). In
human keratinocytes, expression of VEGF-C is strongly upregu-
lated by TGF-a (Fig 5), whereas KGF, HGF, TGF-b1, and IGF-1,
potent inducers of VEGF expression, had no effect. TGF-a also
potently increased VEGF-C mRNA levels in immortalized HaCaT
keratinocytes and in A431 epidermoid carcinoma cells. These
results reveal a distinct regulation of VEGF and VEGF-C gene
expression in keratinocytes. Recently, we observed signi®cant
amounts of VEGF-C mRNA and protein in blood vascular
endothelium adjacent to Kaposi's sarcomas in vivo and have veri®ed
this ®nding using human dermal microvascular endothelial cells
(HDMEC) in vitro (Skobe et al, 1999). Moreover, we found that
VEGF dose-dependently stimulated VEGF-C expression in
HDMEC, whereas no effects were observed upon stimulation
with other growth factors tested, including PDGFs, bFGF, PlGF,
and TNFa. Upregulation of the lymphangiogenic factor VEGF-C
by the major angiogenic factor VEGF reveals a new molecular
mechanism that may regulate blood and lymphatic vessel growth in
concert.
In ®broblasts, VEGF-C is expressed at higher steady-state levels
than VEGF and is induced by serum and by the in¯ammatory
cytokines IL-1a, IL-1b, and TNFa. Hypoxia and oncogenes,
however, important inducers of VEGF expression, had no effect on
VEGF-C expression (Enholm et al, 1997; Ristimaki et al, 1998).
Because dermal ®broblasts are susceptible to alterations of
conditions in the interstitium, it is conceivable that they rapidly
respond to the mechanical stress caused by changes of interstitial
pressure to modulate the function of lymphatic vessels. Thus,
®broblast±lymphatic endothelial cell interactions may be of
particular importance in regulating lymphatic function.
In conclusion, these results indicate a distinct regulation of
VEGF and VEGF-C expression in skin-derived cells. VEGF and
VEGF-C appear to act cooperatively to regulate vascular perme-
ability, lymphatic drainage, blood vascular angiogenesis, and
lymphangiogenesis.
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Figure 4. Expression of the endothelial cell
markers LYVE-1, PAL-E, and CD31 in the
cutaneous vasculature. (A) Double immuno-
¯uorescent staining of LYVE-1 receptor (red) and
PAL-E antigen (green) in 50 mm thick section of
human foreskin. The stainings are mutually exclu-
sive, indicating high speci®city of the LYVE-1 re-
ceptor for lymphatics and of PAL-E for blood
vessels. Note the high lymphatic vessel density.
(B±D) Double immuno¯uorescent staining of
6 mm thick skin sections with antibodies to (B)
CD31 and (C) LYVE-1; (D) overlapping image of
(B) and (C). CD31 is clearly expressed in both
lymphatic (arrows) and blood (arrowheads) vessels.
Note that all lymphatic vessels express CD31.
Dots indicate dermal±epidermal junction. Scale
bar: 20 mm.
Figure 5. Northern blot analysis of VEGF-C mRNA (2.4 kb)
expression in cultured cells derived from human skin. (1)
Melanocytes; (2) keratinocytes; (3) ®broblasts; (4) microvascular endothelial
cells; (5) untreated; and (6) TGFa treated human keratinocytes (100 ng/ml,
6 h). TGFa strongly upregulates expression of VEGF-C in keratinocytes.
Hybridization with a b-actin probe served as a loading control.
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